Leadership Overview
Smith + Nephew has 10 executives leading key functions including information technology, finance, and global business units.
Driven by innovation, Smith + Nephew is dedicated to advancing healthcare solutions across multiple clinical specialties, impacting patient outcomes worldwide through cutting-edge medical technology.
Driven by innovation, Smith + Nephew is dedicated to advancing healthcare solutions across multiple clinical specialties, impacting patient outcomes worldwide through cutting-edge medical technology.
Leadership Roles at Smith + Nephew
Ravi Kumar - Chief Financial Officer & Senior Director, Finance & Anz Senior Finance Business Partner
Ravi Kumar, the Chief Financial Officer & Senior Director, Finance & Anz Senior Finance Business Partner at Smith + Nephew, directs the financial strategy and operations, ensuring fiscal health and driving profitable growth across the organization. Kumar oversees financial planning, reporting, and analysis, providing critical insights to support executive decision-making and investment strategies. This role encompasses managing financial performance for key business units, including the ANZ region, and ensuring compliance with global financial regulations. Ravi Kumar's leadership ensures the financial integrity and strategic allocation of resources necessary for Smith + Nephew's continued expansion in the medical technology sector. The Chief Financial Officer & Senior Director, Finance & Anz Senior Finance Business Partner plays a crucial part in optimizing financial performance and supporting the company's long-term objectives.
Nicolas Celiz - Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs
Nicolas Celiz, the Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs at Smith + Nephew, provides critical financial leadership and oversight for the company's manufacturing, quality assurance, and regulatory affairs functions on a global scale. Celiz ensures robust financial controls and strategic resource allocation to support operational excellence and compliance across these vital areas. This interim leadership role involves driving financial efficiency, managing budgets, and supporting strategic investments in manufacturing capabilities and quality systems. Nicolas Celiz's financial acumen is essential for maintaining the high standards required in the medical device industry and supporting Smith + Nephew's commitment to product safety and efficacy. The Global Interim Chief Financial Officer, Manufacturing Operations, Quality & Regulatory Affairs plays a key part in optimizing financial performance within these complex operational domains.
Katerina Dodbiba - Senior Vice President, Chief Financial Officer - Global Sports Medicine
Katerina Dodbiba, the Senior Vice President, Chief Financial Officer - Global Sports Medicine at Smith + Nephew, directs the financial strategy and operations for the global Sports Medicine division, ensuring fiscal discipline and supporting strategic growth initiatives. Dodbiba oversees financial planning, analysis, and reporting, providing essential insights to guide investment decisions and optimize resource allocation within the division. This leadership role is critical for driving profitability and market expansion for Smith + Nephew's sports medicine products. Katerina Dodbiba's financial expertise supports the development and commercialization of innovative solutions that enhance athletic performance and patient recovery. The Senior Vice President, Chief Financial Officer - Global Sports Medicine ensures financial alignment with the division's objectives, contributing significantly to the company's overall success.
Ted Melo - Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development
Ted Melo, the Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development at Smith + Nephew, provides comprehensive financial leadership for the Advanced Wound Management division and oversees financial strategy for global research and development initiatives. Melo ensures optimal financial performance, manages budgets, and supports strategic investments in innovation and product development across these critical areas. This dual leadership role is essential for driving the growth of advanced wound care solutions and advancing the company's R&D pipeline. Ted Melo's financial acumen supports the successful commercialization of new therapies and technologies, reinforcing Smith + Nephew's commitment to improving patient care. The Senior Vice President, Chief Financial Officer Global Advanced Wound Management and Head of Finance Global Research and Development plays a vital role in financial planning and resource allocation for innovation.
Rebecca Carreon - Executive Assistant To President Global AWM and Chief Human Resources Officer
Rebecca Carreon, the Executive Assistant To President Global AWM and Chief Human Resources Officer at Smith + Nephew, provides critical administrative and strategic support to senior leadership overseeing global advanced wound management and human resources functions. Carreon manages complex scheduling, facilitates communication, and coordinates key initiatives to ensure seamless operations for the President Global AWM and Chief Human Resources Officer. This role is pivotal in supporting the strategic direction of human capital management and the growth of the advanced wound management division. Rebecca Carreon's contributions are essential for maintaining organizational efficiency and supporting the execution of critical business objectives within Smith + Nephew's global structure. The Executive Assistant To President Global AWM and Chief Human Resources Officer ensures alignment across departments and supports the leadership's mandate to drive innovation and talent development.
Rohit Kashyap - Global President, Advanced Wound Management
Rohit Kashyap, the Global President, Advanced Wound Management at Smith + Nephew, directs the strategic vision and operational execution for the company's global advanced wound management business. Kashyap oversees product development, market strategy, and commercial operations, driving innovation and growth in advanced wound care solutions worldwide. This leadership position is critical for addressing the complex needs of patients and healthcare providers in wound management. Rohit Kashyap's focus is on expanding market access and enhancing the efficacy of treatments, reinforcing Smith + Nephew's commitment to improving patient outcomes. The Global President, Advanced Wound Management leads the division's efforts to deliver transformative solutions and maintain market leadership in this specialized healthcare sector.
Guy Hughes - Vice President, Information Technology & Global Regional Chief Information Officer, Commercial & Digital Platforms
Guy Hughes, the Vice President, Information Technology & Global Regional Chief Information Officer, Commercial & Digital Platforms at Smith + Nephew, directs the strategic implementation and operational oversight of information technology across global commercial and digital platforms. Hughes ensures the robust functionality and scalability of IT infrastructure supporting sales, marketing, and customer engagement initiatives worldwide. This leadership role involves architecting digital solutions that enhance market reach and streamline customer interactions, directly contributing to Smith + Nephew's position as a leader in medical technology. Hughes's focus remains on leveraging technology to drive business growth and operational efficiency across diverse international markets. The Vice President, Information Technology & Global Regional Chief Information Officer, Commercial & Digital Platforms oversees the integration of new technologies to support evolving business needs and maintain a competitive edge in the global medical device sector.
Richard Seltz - Senior Vice President and Chief Information Officer
Richard Seltz, the Senior Vice President and Chief Information Officer at Smith + Nephew, architects and executes the company's global information technology strategy, ensuring robust digital infrastructure and cybersecurity across all operations. Seltz oversees the development and deployment of technology solutions that support Smith + Nephew's diverse portfolio, including orthopaedic reconstruction, sports medicine, and advanced wound management. This leadership position involves driving digital transformation initiatives, enhancing data analytics capabilities, and ensuring the secure and efficient operation of IT systems worldwide. Richard Seltz's strategic vision guides the technological advancements that underpin the company's manufacturing, research, and commercial activities. The Senior Vice President and Chief Information Officer champions innovation in IT, fostering an environment that supports the company's mission to improve patient outcomes through advanced medical devices.
Ricardo Salazar - Vice President Chief Information Officer, Orthopaedics and ENT
Ricardo Salazar, the Vice President Chief Information Officer, Orthopaedics and ENT at Smith + Nephew, leads the information technology strategy and execution specifically for the Orthopaedics and Ear/Nose/Throat (ENT) divisions. Salazar ensures that IT systems and digital platforms effectively support the unique operational and strategic needs of these critical business segments, driving innovation and efficiency. This involves overseeing the development and implementation of technology solutions that enhance product development, manufacturing processes, and market access for orthopaedic and ENT devices. Ricardo Salazar's expertise is vital in aligning IT capabilities with the specific growth objectives of these divisions, reinforcing Smith + Nephew's market leadership. The Vice President Chief Information Officer, Orthopaedics and ENT focuses on leveraging technology to advance patient care and surgical outcomes within these specialized fields.
Branislav Jaramaz - Co-Founder & Chief Technology Officer
Branislav Jaramaz, the Co-Founder & Chief Technology Officer at Smith + Nephew, spearheads the company's technological vision and innovation, driving the development of advanced medical devices and solutions. Jaramaz leads research and development efforts, focusing on pioneering new technologies that address unmet clinical needs in areas such as orthopaedics, wound management, and sports medicine. This foundational role involves fostering a culture of innovation and ensuring that technological advancements align with Smith + Nephew's mission to improve patient outcomes globally. Branislav Jaramaz's strategic direction is crucial for maintaining the company's competitive edge and expanding its portfolio of cutting-edge medical technologies. The Co-Founder & Chief Technology Officer guides the technological roadmap, ensuring sustained innovation and market leadership.
Explore Leadership Teams in Manufacturing
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers.
Company Leadership AW
SR
KW

Boston Scientific Corporation is a publicly traded global medical device company headquartered in Marlborough, Massachusetts. Founded in 1979, the company develops, manufactures, and markets minimally invasive medical devices used across a broad range of interventional medical specialties, including interventional cardiology, cardiac rhythm management, electrophysiology, endoscopy, urology, gynecology, oncology, neuromodulation, peripheral interventions, and vascular surgery. The company operates through two primary business segments: MedSurg and Cardiovascular. Its product portfolio includes catheters, stents, defibrillators, pacemakers, guidewires, cardiac monitoring systems, and surgical devices, among others. Boston Scientific serves hospitals, clinics, outpatient facilities, and medical offices worldwide, with manufacturing operations in the United States, Ireland, Costa Rica, Brazil, Malaysia, and Puerto Rico. The company distributes its products directly and through dealer and distributor networks across more than 40 countries globally.
Company Leadership JC

CE
Organogenesis is a leading regenerative medicine company focused on empowering healing through the development, manufacturing, and sale of products for the advanced wound care and surgical and sports medicine markets.
Company Leadership PL
PB

MS
Confluent Applies Materials Science to MedTech Innovation. Confluent's engineered solutions to the most challenging design problems enable our OEM medical device customers to offer life-saving products. Our customers rely on Confluent for materials science and associated manufacturing expertise which is critical to the function and value of their most demanding, high growth products - proprietary expertise which spans processing of high purity Nitinol, ultra-high density knitting of biomedical textiles and precision laser treatment of specialty polymers. Confluent partners with leading OEMs to create a selective product portfolio which includes such complex applications as transcatheter heart valves, neurovascular implants, endovascular stent grafts and advanced smart catheters. With facilities in Fremont and Laguna Niguel, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering and manufacturing.
Company Leadership
JG
EP
ME